SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Accession No. 0001193125-08-245185
Filing Date
2008-11-28
Accepted
2008-11-28 15:42:00
Documents
6
Period of Report
2008-11-28
Filing Date Changed
2008-11-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 9523
  Complete submission text file 0001193125-08-245185.txt   1209083

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT teva-20081107.xml EX-100.INS 108890
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20081107.xsd EX-100.SCH 8364
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20081107_cal.xml EX-100.CAL 70122
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20081107_lab.xml EX-100.LAB 67069
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20081107_pre.xml EX-100.PRE 942858
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 081220469
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1